Switching from In-Person to Telehealth Ketamine: A Guide to Transitioning Your Care

Why Patients Switch to Telehealth

Many patients who started ketamine therapy at in-person clinics — whether receiving IV infusions, intramuscular injections, or supervised nasal spray treatments — eventually consider transitioning to telehealth. The reasons are practical and varied:

• Cost — In-person IV infusions typically cost $400 to $800 per session, while at-home sublingual or oral ketamine through telehealth providers often ranges from $150 to $350 per session including medication
• Convenience — Eliminating 2 to 4 hours of travel and clinic time per session
• Relocation — Moving to an area without a nearby ketamine clinic
• Sustainability — Maintenance treatment over months or years is more feasible from home
• Comfort — Some patients prefer the familiar, relaxed environment of their own home
• Schedule flexibility — Telehealth sessions can be booked outside traditional business hours

Whatever the reason, switching from in-person to telehealth ketamine therapy requires thoughtful planning to maintain treatment effectiveness and safety.

Key Differences Between In-Person and Telehealth Ketamine

Understanding what changes — and what does not — when you switch to telehealth is essential.

Route of Administration

This is typically the biggest change. In-person clinics most commonly provide:

• Intravenous (IV) infusions — Delivered directly into the bloodstream, with precise dosing control
• Intramuscular (IM) injections — Rapid absorption, administered by a clinician
• Supervised nasal spray — Spravato (esketamine) in a REMS-certified clinic

Telehealth providers typically prescribe:

• Sublingual troches or tablets — Dissolved under the tongue at home
• Oral ketamine tablets — Swallowed, with lower bioavailability than sublingual
• Nasal spray (compounded) — Self-administered at home (not Spravato, which requires in-clinic supervision)

The shift from IV/IM to sublingual or oral delivery means different bioavailability, onset times, and subjective experiences. IV ketamine has approximately 100% bioavailability, while sublingual is roughly 25-35% and oral is approximately 15-20%. Your telehealth provider will adjust dosing to account for these differences.

Monitoring

In-person clinics typically monitor vital signs (blood pressure, heart rate, oxygen saturation) continuously during infusions. Telehealth monitoring relies on:

• Self-reported vital signs — You may be asked to take your blood pressure before and during sessions
• Video observation — Your provider watches you via video during dosing sessions
• Support person — A sitter who can observe you in person and communicate with the provider

This shift in monitoring is manageable for most patients but requires you to take a more active role in your own safety. Review our safety protocols guide for details.

Treatment Environment

At a clinic, the environment is designed for treatment — reclining chairs, dim lighting, curated music, and trained staff nearby. At home, you create this environment yourself. See our set and setting guide for how to set up an effective treatment space.

How to Make the Transition

Step 1: Talk to Your Current Provider

Before switching, discuss the transition with your in-person provider. They can:

• Provide your complete treatment records, including dosing history, response patterns, and any adverse events
• Offer a clinical summary or referral letter for your new telehealth provider
• Advise on whether telehealth is appropriate given your specific clinical situation
• Suggest a timeline for the transition (gradual vs. immediate)

Some patients are not ideal candidates for unsupervised at-home treatment. If your in-person provider has concerns, take them seriously.

Step 2: Choose a Telehealth Provider

Not all telehealth ketamine providers are equivalent. When selecting one, prioritize:

• Medical credentials — Board-certified psychiatrists or experienced psychiatric nurse practitioners
• Experience with transitions — Providers who regularly accept patients from in-person programs understand dose conversion
• Monitoring protocols — How will they observe you during sessions? What emergency procedures are in place?
• Communication — Can you reach someone between sessions if you have concerns?
• Transparent pricing — Understand all costs upfront, including medication, shipping, and follow-up visits

For a detailed evaluation framework, see our guide on what to look for in a telehealth provider.

Step 3: Transfer Your Records

Your new telehealth provider needs a complete picture of your treatment history. Prepare:

• Treatment dates and doses — Every infusion or session, with the dose administered
• Clinical response — PHQ-9 or other standardized scores over time, if available
• Adverse events — Any side effects, bad reactions, or complications
• Current medications — Complete list with doses
• Diagnosis — Formal diagnosis from your treating provider
• Lab results — Recent bloodwork, liver function, or other relevant tests

Most clinics will release records with a signed authorization. Request these well before your first telehealth appointment.

Step 4: Expect a Dose Adjustment Period

Switching from IV to sublingual or oral ketamine is not a simple 1:1 dose conversion. Your telehealth provider will likely:

• Start at a conservative dose and titrate upward based on your response
• Schedule more frequent check-ins during the first few weeks of the transition
• Ask for detailed feedback on how the at-home experience compares to your in-person sessions
• Adjust based on therapeutic response — The goal is to replicate or improve upon the benefit you experienced with IV treatment

Be patient during this period. It may take 2 to 4 sessions to find the right at-home dose. Some patients find that sublingual ketamine provides a different but equally therapeutic experience; others need time to adapt.

Step 5: Set Up Your Home Treatment Space

If you have been going to a clinic, you have never had to think about your treatment environment. Now you do. Essential preparation includes:

• Designate a room — Quiet, private, comfortable, and safe
• Gather supplies — Blood pressure cuff, water, blankets, eye mask, headphones, tissues, emesis bag
• Arrange a support person — Especially for your first few at-home sessions
• Test your technology — Ensure your video setup works reliably for provider monitoring
• Create a playlist — Many patients use music during sessions; prepare this in advance

Our equipment guide covers everything you need in detail.

Common Challenges in the Transition

The Experience Feels Different

Patients frequently report that sublingual ketamine feels different from IV infusions. The onset is slower (15 to 30 minutes vs. immediate), the peak is less intense, and the duration may be longer. This is normal. Different does not mean less effective.

Some patients actually prefer the gentler onset of sublingual administration. Others miss the intensity of IV treatment. Give yourself at least 4 to 6 sessions before making a judgment about whether the new format works for you.

Feeling Less "Safe" at Home

The presence of medical staff at an in-person clinic provides a psychological sense of safety. Losing this can cause anxiety during your first few at-home sessions. Strategies to address this:

• Have your support person sit with you during the full session (not just nearby)
• Keep your provider's emergency number visible
• Start with a lower dose to build confidence in the at-home setting
• Remember that you are still being monitored via video
• Review our emergency response guide before your first session

Insurance and Cost Changes

If your in-person treatment was partially covered by insurance (common with Spravato), switching to compounded sublingual ketamine through telehealth may mean paying entirely out of pocket. On the other hand, the per-session cost is usually much lower. Run the numbers before switching:

For comprehensive cost information, see our cost comparison guide.

Maintaining Integration Therapy

If your in-person clinic offered integration therapy (psychotherapy sessions that help you process ketamine experiences), ensure this continues during your transition. Options include:

• Continuing with the same therapist via their own telehealth sessions
• Finding a new therapist experienced in ketamine integration
• Using your telehealth ketamine provider's integration services if offered

Integration therapy significantly enhances ketamine's long-term effectiveness. Do not let it fall away during the transition. Learn more in our integration support guide.

When Switching May Not Be Right

Consider staying with in-person treatment if:

• You have a history of severe adverse reactions that required medical intervention
• You have uncontrolled cardiovascular conditions that need real-time vital sign monitoring
• You live alone and cannot reliably arrange a support person for sessions
• Your condition is not yet stabilized — The initial acute treatment phase may be safer in a supervised setting
• You have active suicidal ideation — Close in-person monitoring may be more appropriate until stabilized
• Your provider advises against it based on your clinical profile

Some patients benefit from a hybrid approach: completing the initial series of treatments in-person, then transitioning to telehealth for maintenance sessions.

The Bottom Line

Switching from in-person to telehealth ketamine therapy can save time and money while maintaining treatment effectiveness, but it requires careful planning. Transfer your records, choose a qualified telehealth provider, expect a dose adjustment period, set up your home environment properly, and maintain integration therapy. Most importantly, communicate openly with both your old and new providers throughout the transition.

If you are new to evaluating telehealth options, start with our comprehensive guide to telehealth ketamine and how telehealth ketamine works.

References

• Ketamine Bioavailability by Route of Administration — NIH National Library of Medicine — Pharmacokinetic data on different ketamine administration routes
• Sublingual vs. Intravenous Ketamine for Depression — Journal of Clinical Psychiatry — Comparative research on ketamine delivery methods
• Telehealth for Mental Health Services — American Psychiatric Association — APA guidelines on telehealth psychiatric care
• At-Home Ketamine Safety — National Library of Medicine — Research on safety outcomes in at-home ketamine programs
• Ketamine Integration Therapy — NIMH — NIMH overview of psychotherapy approaches including integration work
• Patient Transition Between Care Settings — WHO — WHO guidance on maintaining continuity during care transitions